Snowball logo
logo
6876

LAUNXP Biomedical Co., Ltd

6876 TWO
NT$11.20NT$0.00  (0%)
Estimate
EPS
-2.78
Beta
-0.103
About the company
Ticker
6876
ISIN
TW0006876006
Country
Taiwan
Sector (GICS)
Other
LAUNXP Biomedical Co., Ltd engages in the research and development of drugs for cancer patients. It develops various drugs, which are in preclinical stage, including LXP5948 for non-small cell lung cancer and Alzheimer's disease; LXP5268 for triple negative breast cancer; LXP5101 for pancreatic cancer; LXP1788 for gastrointestinal cancer; and Virus-like particles for cancer and genetic defect treatment. The company was founded in 2015 and is based in Taichung, Taiwan.

Frequently asked questions

What sector does LAUNXP Biomedical Co., Ltd (6876) operate in?

LAUNXP Biomedical Co., Ltd belongs to the Other sector and operates in the Biotechnology industry.

What is LAUNXP Biomedical Co., Ltd (6876) current stock price?

As of the latest data, LAUNXP Biomedical Co., Ltd stock price is NT$11.20, with a previous close of NT$11.20.

What is LAUNXP Biomedical Co., Ltd (6876) current market capitalization?

LAUNXP Biomedical Co., Ltd market cap is approximately 791.79 million.

What is LAUNXP Biomedical Co., Ltd (6876) Earnings Per Share (EPS)?

The trailing EPS is -NT$2.78.

Does LAUNXP Biomedical Co., Ltd (6876) pay dividends?

No. LAUNXP Biomedical Co., Ltd does not pay a dividend.

What is LAUNXP Biomedical Co., Ltd (6876) beta (volatility) score?

LAUNXP Biomedical Co., Ltd has a beta of -0.103, indicating lower volatility than the overall market.